These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21298051)

  • 1. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
    Ng OT; Lin L; Laeyendecker O; Quinn TC; Sun YJ; Lee CC; Leo YS
    PLoS One; 2011 Jan; 6(1):e15738. PubMed ID: 21298051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After 18 months of antiretroviral therapy, total HIV DNA decreases more pronouncedly in patients infected by CRF01_AE than in those infected by subtype B and CRF07_BC.
    Lu Z; Jiao Y; Li J; Lan G; Lu C; Li X; Tang Z; Wang N
    Microbiol Immunol; 2018 Apr; 62(4):248-254. PubMed ID: 29377267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
    Lyu T; Yue Y; Hsieh E; Han Y; Zhu T; Song X; Cao W; Lyu W; Wang J; Li T
    BMC Infect Dis; 2020 Jan; 20(1):66. PubMed ID: 31964364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China.
    Li X; Xue Y; Zhou L; Lin Y; Yu X; Wang X; Zhen X; Zhang W; Ning Z; Yue Q; Fu J; Shen F; Gai J; Xu Y; Mao J; Gao X; Shen X; Kang L; Vanham G; Cheng H; Wang Y; Zhuang M; Zhuang X; Pan Q; Zhong P
    PLoS One; 2014; 9(2):e89462. PubMed ID: 24586795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.
    Ng KY; Chew KK; Kaur P; Kwan JY; Khong WX; Lin L; Chua A; Tan MT; Quinn TC; Laeyendecker O; Leo YS; Ng OT
    BMC Infect Dis; 2013 Feb; 13():90. PubMed ID: 23421710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.
    Touloumi G; Pantazis N; Pillay D; Paraskevis D; Chaix ML; Bucher HC; Kücherer C; Zangerle R; Kran AM; Porter K;
    Clin Infect Dis; 2013 Mar; 56(6):888-97. PubMed ID: 23223594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Genetic Diversity and Its Impact on Baseline CD4+T Cells and Viral Loads among Recently Infected Men Who Have Sex with Men in Shanghai, China.
    Li X; Xue Y; Cheng H; Lin Y; Zhou L; Ning Z; Wang X; Yu X; Zhang W; Shen F; Zheng X; Gai J; Li X; Kang L; Nyambi P; Wang Y; Zhuang M; Pan Q; Zhuang X; Zhong P
    PLoS One; 2015; 10(6):e0129559. PubMed ID: 26121491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy.
    Wei L; Li H; Lv X; Zheng C; Li G; Yang Z; Chen L; Han X; Zou H; Gao Y; Cheng J; Wang H; Zhao J
    Retrovirology; 2021 Aug; 18(1):22. PubMed ID: 34399785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.
    Zhao K; Kang W; Liu Q; Li Y; Liu Q; Jiang W; Zhuang Y; Guo Z; Yu Z; Li X; Wang C; Yao N; Sun Y
    PLoS One; 2014; 9(10):e109821. PubMed ID: 25333965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid CD4+ T-cell decline is associated with coreceptor switch among MSM primarily infected with HIV-1 CRF01_AE in Northeast China.
    Cui H; Geng W; Sun H; Han X; An M; Jiang Y; Zhang Z; Chen Z; Xu J; Hu Q; Zhao B; Zhou B; Shang H
    AIDS; 2019 Jan; 33(1):13-22. PubMed ID: 30102662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission.
    Li Y; Han Y; Xie J; Gu L; Li W; Wang H; Lv W; Song X; Li Y; Routy JP; Ishida T; Iwamoto A; Li T;
    AIDS; 2014 Feb; 28(4):521-30. PubMed ID: 24472744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HIV-1 genetic diversity on disease progression: a prospective cohort study in Guangxi.
    Pang X; Huang J; Tang K; Ma J; Fang N; Xie H; He Q; Zhu Q; Lan G; Liang S
    Front Cell Infect Microbiol; 2024; 14():1415123. PubMed ID: 38994006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
    Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
    PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between HIV genotype, viral load and disease progression in a cohort of Thai men who have sex with men with estimated dates of HIV infection.
    Leelawiwat W; Pattanasin S; Sriporn A; Wasinrapee P; Kongpechsatit O; Mueanpai F; Tongtoyai J; Holtz TH; Curlin ME
    PLoS One; 2018; 13(7):e0201386. PubMed ID: 30063722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B.
    Lau KA; Wang B; Miranda-Saksena M; Boadle R; Kamarulzaman A; Ng KP; Saksena NK
    Curr HIV Res; 2010 Apr; 8(3):259-71. PubMed ID: 20214658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.
    Oyomopito RA; Li PC; Sungkanuparph S; Phanuphak P; Tee KK; Sirisanthana T; Kantipong P; Oka S; Lee CK; Kamarulzaman A; Choi JY; Sohn AH; Law M; Chen YM;
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):293-300. PubMed ID: 23138836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals.
    Li K; Chen H; Li J; Feng Y; Lan G; Liang S; Liu M; Rashid A; Xing H; Shen Z; Shao Y
    Emerg Microbes Infect; 2022 Dec; 11(1):158-167. PubMed ID: 34895083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.
    Easterbrook PJ; Smith M; Mullen J; O'Shea S; Chrystie I; de Ruiter A; Tatt ID; Geretti AM; Zuckerman M
    J Int AIDS Soc; 2010 Feb; 13():4. PubMed ID: 20205896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.
    Ghosn J; Bayan T; Meixenberger K; Tran L; Frange P; d'Arminio Monforte A; Zangerle R; de Mendoza C; Krastinova E; Porter K; Meyer L; Chaix ML;
    J Antimicrob Chemother; 2017 Oct; 72(10):2862-2868. PubMed ID: 29091208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4
    Li K; Chen H; Li J; Feng Y; Liang S; Rashid A; Liu M; Li S; Chu Q; Ruan Y; Xing H; Lan G; Qiao W; Shao Y
    mBio; 2024 Mar; 15(3):e0334923. PubMed ID: 38385695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.